title: State-of-the-art lymph node staging for breast cancer in the year 2000.
abstract: Axillary staging for breast cancer is vitally important for determining appropriate adjuvant hormone and chemotherapy. In the absence of distant metastases, axillary lymph node status remains the most accurate predictor of clinical outcome. Sentinel lymph node biopsy is a minimally invasive approach with enhanced accuracy and less morbidity than conventional axillary dissection. The stage is now set for the sentinel lymphadenectomy staging to move from state-of-the-art care to the standard care in coming years.
authors: Nashville Breast Center, Nashville, Tennessee, USA.
authors: P
authors: P
authors: Whitworth
authors: K M
authors: KM
authors: McMasters
authors: L
authors: L
authors: Tafra
authors: M J
authors: MJ
authors: Edwards
mesh_terms: D001365:Axilla; D001943:Breast Neoplasms / Q000473:pathology* / Q000601:surgery; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging; D018579:Patient Selection; D011788:Quality of Life; D021701:Sentinel Lymph Node Biopsy